Review
Version 1
Preserved in Portico This version is not peer-reviewed
Nano-Therapeutic Approaches to Treat COVID Induced Pulmonary Fibrosis
Version 1
: Received: 27 March 2023 / Approved: 28 March 2023 / Online: 28 March 2023 (03:59:29 CEST)
A peer-reviewed article of this Preprint also exists.
Kanvinde, S.; Deodhar, S.; Kulkarni, T.A.; Jogdeo, C.M. Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary Fibrosis. BioTech 2023, 12, 34. Kanvinde, S.; Deodhar, S.; Kulkarni, T.A.; Jogdeo, C.M. Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary Fibrosis. BioTech 2023, 12, 34.
Abstract
There have been significant collaborative efforts over the past three years to develop therapies against COVID-19. During this journey, there has also been a lot of focus on understanding at-risk groups of patients who either have pre-existing conditions or have developed concomitant health conditions due to the impact of COVID-19 on immune system. There was a high incidence of COVID-19 induced pulmonary fibrosis (PF) observed in patients. PF can cause significant morbidity, long-term disability, and lead to death in the long run. Additionally, being a progressive disease, PF can also impact the patient for a long time after COVID infection and affect the overall quality of life. Although current therapies are being used as the mainstay for treating PF, there is no therapy specifically for COVID-induced PF. As observed in the treatment of other diseases, nanomedicine can show a significant promise in overcoming the limitations of current anti-PF therapies. In this review, we summarize the efforts reported by various groups to develop nanomedicine therapeutics to treat COVID-induced PF.
Keywords
SARS-CoV-2; COVID-19; pulmonary fibrosis; coronavirus; nanoparticles; nanomedicine; pandemic; acute respiratory syndrome
Subject
Medicine and Pharmacology, Pulmonary and Respiratory Medicine
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment